Clinical Trial

The KAEPacity Study Analyzes Hospital Emergency and Disaster Plans From Hospitals Across Germany to Evaluate How Well Hospitals Are Prepared for Crises and Disasters Organizational Structures Communication Leadership Training Are Examined Within These Plans No Medical Intervention is Performed

Study acronym: KAEPacity
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 11, 2026 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Hospital Emergency and Disaster Plans (Krankenhausalarm- und Einsatzplan-KAEP) are a central component of hospital preparedness in Germany. Despite national and international recommendations, considerable variability exists in structure, responsibilities, communication pathways, and training concepts across hospitals. This study aims to systematically analyze and compare KAEP documents from German hospitals using a structured qualitative and quantitative document analysis. The goal is to identify strengths, deficits, institutional influencing factors, and best-practice elements to support evidence-based improvements and harmonization of hospital emergency planning.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-23.
Status change: Not Yet Recruiting → Recruiting 2026-03-09
Trial Details
NCT Number NCT07440329
Lead Sponsor Lea Kölsch
Collaborators: University Hospital Heidelberg, Prof. Erik Popp - Head, Department of Crisis and Disaster Management, Prof. Markus Ries - Head of Research, Department of Crisis and Disaster Management, Hanne Schäfer - Head of Operational KAEP, Department of Crisis and Disaster Management, PD Dr. med. Fabian Weykamp - Senior Physician, Department of Radiotherapy, Dr. med. Maik von der Forst - Deputy Head, Department of Crisis and Disaster Management
Conditions Disaster Planning, Emergency Medical Services, Germany
Enrollment 319 participants
Start Date 2026-03-09
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-11